Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2)

Histochemistry and Cell Biology

Volumn 110, Issue 6, 1998, Pages 559-569

  Risse, Barbara C ^a   Brown, Heather ^a   Lavker, Robert M ^a   Pearson, Julia M ^b   Baker, Mark S ^c   Ginsburg, David ^b   Jensen, Pamela J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 2;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ESOPHAGUS MUCOSA; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN EPITHELIUM; SQUAMOUS EPITHELIUM; TISSUE DISTRIBUTION; TONGUE;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; EPIDERMIS; EPITHELIAL CELLS; ESOPHAGUS; FEMALE; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, INBRED SENCAR; MOUTH MUCOSA; PLASMINOGEN ACTIVATOR INHIBITOR 2; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TONGUE; VAGINA;

EID: 0031727899     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050318     Document Type: Article

References (54)

1. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68:1-19
2. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
3. Ashkenas J, Werb Z (1996) Proteolysis and the biochemistry of life-or-death decisions. J Exp Med 183:1947-1951
4. Belin D, Wohlwend A, Schleuning W-D, Kruithof EKO, Vassalli J-D (1989) Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activator inhibitor 2. EMBO J 8:3287-3294
5. Boyle MDP, Lottenberg R (1997) Plasminogen activation by invasive human pathogens. Thromb Haemost 77:1-10
6. Carmeliet P, Collen D (1995) Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 74:429-436
7. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
8. Dickinson JL, Bates EJ, Ferrante A, Antalis TM (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. J Biol Chem 270:27894-27904
9. Dickinson JL, Norris BL, Jensen PH, Antalis TM (1998) The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α-induced apoptosis. Cell Death Differ 5:163-171
10. Eckert RL, Rorke EA (1989) Molecular biology of keratinocyte differentiation. Environ Health Perspect 80:109-116
11. Fesus L, Davies PJA, Piacentini M (1991) Apotposis: molecular mechanism in programmed cell death. Eur J Cell Biol 56: 170-177
12. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-626
13. Fujimoto W, Nakanishi G, Arata J, Jetten AM (1997) Differential expression of human cornifin a and b in squamous differentiating epithelial tissues and skin lesions. J Invest Dermatol 108: 200-204
14. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
15. Green H (1977) Terminal differentiation of cultured human epidermal cells. Cell 11:405-416
16. Green H (1980) The keratinocyte as differentiated cell type. Harvey Lec 74:101-139
17. Hall PA, Coates PJ, Ansari B, Hopwood D (1994) Regulation of cell number in the mammalian gastrointestinal tract - the importance of apoptosis. J Cell Sci 107:3569-3577
18. Hibino T, Izaki S, Ohkuma M, Kon S, Thorsen S, Astedt B (1988) Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2. FEBS Lett 231:202-206
19. Hohl D, Roop D (1993) Loricrin. In: Darmon M, Blumenberg M (eds) Molecular biology of the skin: the keratinocyte. Academic Press, San Diego, pp 151-179
20. Jensen PH, Lorand L, Ebbesen P, Glieman J (1993) Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur J Biochem 214:141-146
21. Jensen PH, Schuler E, Woodrow G, Richardson M, Goss N, Hojrup P, Peterson TE, Rasmussen LK (1994a) A unique interhelical insertion in plasminogen activator inhibitor 2 contains three glutamines, Gln83 Gln84 Gln86. essential for transglutaminase-mediated cross-linking. J Biol Chem 269:15394-15398
22. Jensen PH, Cressey LI, Gjertsen BT, Madsen P, Mellgren G, Hokland P, Gliemann J, Døskeland SO, Lanotte M, Vintermyr OK (1994b) Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukemia cells is a marker of apoptosis. Br J Cancer 70:834-840
23. Jensen PJ, Lavker RM (1996) Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo. Cell Growth Differ 7:1793-1804
24. Jensen PJ, Wu Q, Janowitz P, Ando Y, Schlechter NM (1995) Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp Cell Res 217:65-71
25. Kawata Y, Mimuro J, Kaneko M, Shimada K, Sakata Y (1996) Expression of plasminogen activator inhibitor 2 in the adult and embryonic mouse tissues. Thromb Haemost 76:569-576
26. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff D (1993) Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 142:59-70
27. Komiyama T, Long TQ, Salvesen GS (1996) Inhibition of cysteine and serine proteinases by the cowpox virus serpin crmA. Adv Exp Med Biol 389:173-176
28. Korhonen TK, Lähteenmäki K, Kukkonen M, Pouttu R, Hynönen U, Savolainen K, Westerlund-Wikström B, Virkola R (1997) Plasminogen receptors. Turning Salmonella and Escherichia coli into proteolytic organisms. Adv Exp Med Biol 412:185-192
29. Kruithof EKO, Bakers MS, Bunn CL (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86:4007-4024
30. Kumar S, Baglioni C (1991) Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 266:20960-20964
31. Lyons-Giordano B, Loskutoff D, Chen CS, Lazarus GS, Keeton M, Jensen PJ (1994) Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Histochemistry 101:105-112
32. Mars WM, Zarnegar R, Michalopoulos GK (1993) Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 143:949-958
33. Metcalfe A, Streuli C (1997) Epithelial apoptosis. Bioessays 19: 711-720
34. Mikus P, Urano T, Liljeström P, Ny T (1993) Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising serpin. Biochemical characterisation of the recombinant intracellular and extracellular forms. Eur J Biochem 218:1071-1082
35. Naldini T, Tamagone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM (1992) Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11:4825-4833
36. Parenteau NL, Pilato A, Rice RH (1986) Induction of keratinocyte type-I transglutaminase in epithelial cells of the rat. Differentiation 33:130-141
37. Pfundt R, Ruissen F van, Vlijmen-Willems IMJJ van, Alkemade HAC, Zeeuwen PLJM, Lap PH, Dijkman H, Fransen J, Croes H, Erp PEJ van, Schalkwijk J (1996) Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest 98:1389-1399
38. Polakowska RR, Haake AR (1994) Apoptosis: the skin from a new perspective. Cell Death Differ 1:19-31
39. Pullan S, Wilson J, Edwards GM, Goberdhan N, Tilly J, Hickman JA, Dive C, Streuli CH (1996) Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 109:631-642
40. Quigley JP, Gold LI, Schwimmer R, Sullivan LM (1987) Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci USA 84:2776-2780
41. Reibel J, Clausen H, Dale BA, Thacher SM (1989) Immunohistochemical analysis of stratum corneum components in oral squamous epithelia. Differentiation 41:237-244
42. 2+ in the second stage. J Biol Chem 268:25139-25145
43. Rice RH, Green H (1979) Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18:681-694
44. Robinson NA, Lapic S, Welter JF, Eckert RL (1997) S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope in cultured human epidermal keratinocytes. J Biol Chem 272:12035-12046
45. L expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci USA 94: 5067-5072
46. Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Danø K (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287-292
47. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schlechter NM, Pemberton PA, Silverman GA (1997) Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsinlike proteinases cathepsin G and mast cell chymase. J Biol Chem 272:1849-1855
48. Scott FL, Coughlin PB, Bird C, Cerruti L, Hayman JA, Bird P (1996) Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J Biol Chem 271: 1605-1612
49. Tamada Y, Takama H, Kitamura T, Yokochi K, Nitta Y, Ikeya T, Matsumoto Y (1994) Identification of programmed cell death in normal human skin tissues by using specific labelling of fragmented DNA. Br J Dermatol 131:521-524
50. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552
51. Wang Y, Jensen PJ (1998) Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during keratinocyte differentiation. Differentiation 63:93-99
52. Wohlwend A, Belin D, Vassalli J-D (1987a) Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J Immunol 139:1278-1284
53. Wohlwend A, Belin D, Vassalli J-D (1987b) Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J Exp Med 165:320-339
54. Ye RD, Wun RC, Sadler JE (1988) Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J Biol Chem 263:4869-4875